| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |